Publications SOMA.GUT

  • Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
    Löwe B, Nestoriuc, Y, Andresen V, Vettorazzi E, Zapf A, Hübener S, Maheder K, Peters L, Lohse AW.
    BMJ OPEN 2022;12:e059529. doi: 10.1136/bmjopen-2021-059529

    Find the publication here

    Psychosoziale Unterstützung von Menschen mit Colitis ulcerosa und Reizdarmsyndrom: eine Machbarkeitsstudie zu Bedarf, Fokus und Durchführbarkeit.
    Uhlenbusch N, Manthey C, Nestoriuc Y, Andresen V, Lohse AW, Löwe B.
    PSYCHOTHER PSYCH MED. 2022; doi: 10.1055/a-1785-5496

    Find the publication here

  • Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial.
    Shedden-Mora MC, Pan Y, Heisig SR, Blanckenburg Pv, Rief W, Witzel I, Albert US, Nestoriuc Y.
    CLIN PSYCH EUROPE. 2020;2(1):e2695.

    Find the publication here

    Functional somatic disorders: discussion paper for a new common classification for research and clinical use.
    Burton C, Fink P, Henningsen P, Löwe B, Rief W, EURONET-SOMA GROUP.
    BMC MEDICINE. 2020;18:34-34.

    Find the publication here

    Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial.
    Pan Y, Meister R, Löwe B, Winkelmann A, Kaptchuk TJ, Buhling KJ, Nestoriuc Y.
    TRIALS. 2019;20(1):508.

    Find the publication here

    The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.
    Löwe B, Lohse A, Andresen V, Vettorazzi E, Rose M, Broicher W.
    AM J GASROENTEROL. 2016;111:1320-1329.

    Find the publication here

    Determinants and frequency of irritable bowel syndrome in a German sample.
    Althaus A, Broicher W, Wittkamp P, Andresen V, Lohse AW, Löwe B.
    Z GASTROENTEROL. 2016;54:217-225.

    Find the publication here

    Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up.
    Andresen V, Löwe B, Broicher W, Riegel B, Fraedrich K, von Wulffen M, Gappmayer K, Wegscheider K, Treszl A, Rose M, Layer P, Lohse AW.
    UNITED EUROPEAN GASTROENTEROL J. 2016;4:121-131.

    Find the publication here

    Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study.
    Lehmann M, Brünahl CA, Addo MM, Becker S, Schmiedel S, Lohse AW, Schramm C, Löwe B.
     J PSYCHOSOM RES. 2016;83:69-74.

    Find the publication here

    Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.
    Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, Rief W.
    ANN ONCOL. 2016;27:1909-1915.

    Find the publication here

    Psychological outcome, fatigue, and quality of life after infection with shiga toxin-producing Escherichia coli O104.
    Löwe B, Andresen V, Fraedrich K, Gappmayer K, Wegscheider K, Treszl A, Riegel B, Rose M, Lohse AW, Broicher W.
    CLIN GASTROENTEROL HEPATOL. 2014;12:1848-1855.

    Find the publication here

    Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis.
    Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse AW, Rose M.
    J HEPATOL. 2014;60:618-624.

    Find the publication here

  • Somatische Belastungsstörung bei Reizdarmsyndrom und Colitis ulcerosa: Querschnittsergebnisse des SOMA.GUT-RCT
    [Somatic Symptom Disorder in Irritable Bowel Syndrome and Ulcerative Colitis: Cross-Sectional Results from the SOMA.GUT RCT]
    Peters L, Maehder K, Hübener S, Matysiak A, Lohse A., Löwe B.
    German Congress for Psychosomatic Medicine and Psychotherapy, 12.-14. March 2025, Berlin.
    [Lecture, 14. March 2025]

    Somatic Symptom Disorder in patients with Irritable Bowel Syndrome and Ulcerative Colitis – cross-sectional findings from the SOMA.GUT-RCT
    Peters L, Maehder K, Hübener S, Matysiak A, Andresen V, Nestoriuc Y, Lohse A, Löwe B.
    International Conference on Process Mining, 19.-21. September 2024, Tübingen.
    [Lecture, 21. September 2024]

    Persistence of Gastrointestinal Symptoms in Irritable Bowel Syndrome and Ulcerative Colitis - Study design and baseline data of the SOMACROSS Research Unit SOMA.GUT-RCT
    Maehder K, Peters L, Hübener S, Matysiak A, Lohse A, Löwe B.
    International Conference on Process Mining, 19.-21. September 2024, Tübingen.
    [Lecture, 19. September 2024]

    Persistence of Gastrointestinal Symptoms in Irritable Bowel Syndrome and Ulcerative Colitis: From Risk Factors to Modification.
    Löwe B, Lohse AW, Andresen V, Nestoriuc Y, Maehder K, Peters L, Hübener S.
    DGNM-Annual Meeting, Berlin, 5. March 2023.
    [Lecture, 05. March 2023]

    Persistierende gastrointestinale Symptome bei Reizdarmsyndrom und Colitis Ulcerosa: SOMACROSS Projekt 2
    [Persistent Gastrointestinal Symptoms in Irritable Bowel Syndrome and Ulcerative Colitis: SOMACROSS Project 2]
    Maehder K, Andresen V, Hübener S, Lohse A, Nestriuc Y, Peters L, Löwe B.
    German Congress for Psychosomatic Medicine and Psychotherapy, 22.-24. June 2022, Berlin.
    [Lecture, 23. June 2022]

    Persistence of Gastrointestinal Symptoms in Irritable Bowel Syndrome and Ulcerative Colitis - Study protocol of the SOMACROSS Research Unit Project 02
    Peters L, Maehder K, Hübener S, Nestoriuc Y, Andresen V, Vettorazzi E, Zapf A, Lohse A, Löwe B.
    European Association of Psychosomatic Medicine, 08.-11. June 2022, Vienna.
    [Poster]